Amid the ongoing selloff on Dalal Street triggered by US Fed’s hawkish than expected commentary, it is becoming tougher to buy stocks. While bank stocks are the worst affected, defensives like pharma, IT and FMCG are outperforming. Smallcaps are looking more vulnerable.